PART
LIVE

Serial Number

97260868

Owner

Affinia Therapeutics Inc.

Attorney

John Paul Oleksiuk

Filing Date

Feb 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PART Trademark

Serial Number: 97260868 • Registration: 7210201

PART is a trademark filed by Affinia Therapeutics Inc. on February 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Affinia Therapeutics Inc. (12 trademarks)

43 Foundry Avenue, Suite 120
Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

February 10, 2022

Registration Date

November 7, 2023

Published for Opposition

August 22, 2023

Goods & Services

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 7, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 22, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 22, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2023 CRFA
ASSIGNED TO LIE
Jul 12, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 26, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 26, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2022 NWOS
NEW APPLICATION ENTERED
Feb 14, 2022 NWAP